CAR T Therapy Extends Cancer Victory to Autoimmune Disease

CAR T cell therapy, originally developed to fight blood cancers, is expanding into autoimmune disease treatment through hundreds of clinical trials. The approach aims to reprogram patients' immune systems to reset their defense mechanisms, potentially offering relief to millions suffering from conditions like multiple sclerosis and lupus. However, the transition raises important questions about long-term effectiveness and safety risks that researchers must carefully evaluate.